Yahoo Finance

PMV Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Progress Update on PYNNACLE Clinical Trial

PMV Pharma ended the second quarter with $212.9 million in cash, cash equivalents, and marketable securities, compared to $213.1 million as of March 31, 2024. Net cash used in operations was $17.8 ...
Yahoo Finance

PMV Pharmaceuticals Announces Initial PC14586 Phase 1 Clinical Data to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

CRANBURY, N.J., May 26, 2022 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP; "PMV Pharma"), a precision oncology company pioneering the discovery and development of small molecule, ...
MedCity News

PMV’s ASCO data show signs of drugging ‘undruggable’ p53 protein across tumor types

The tumor-suppressing protein p53 has long been considered a valuable target—if only drug hunters could figure out how to hit it. Many research efforts aiming to leverage the capabilities of this ...
BioWorld

PMV’s rezatapopt wows in ovarian cancer in early phase II readout

PMV Pharmaceuticals Inc.’s rezatapopt yielded impressive overall response data in ovarian cancer, prompting the firm to aim for a potential accelerated approval filing in early 2027. The news caused ...
Mint

PMV’s compact electric car to launch this November: Know what this EV offers

PMV Electric says that their first car will get a digital infotainment system and a USB charging port(PMV) 0 PMV, a Mumbai based electric vehicle manufacturer, is all set to launch its micro-electric ...